Warning
Blossom Pharmaceuticals Recalls Wecare Calasoothe, Net wt
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0213-2026Drug / Pharmaceutical
Blossom Pharmaceuticals Recalls Wecare Calasoothe, Net wt
Blossom Pharmaceuticals · Class II — Moderate Risk
Product Description
Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, NDC 67777-234-04.
Reason for Recall
cGMP deviations
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
USA Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Blossom Pharmaceuticals initiated the recall on October 31, 2025 affecting 2400 containers. cGMP deviations. The product was distributed in USA Nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact Blossom Pharmaceuticals for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.